Leveraging Technology to Cut Through the REMS Confusion

The Risk Evaluation and Mitigation Strategies (REMS) program has taken center stage recently as the Food and Drug Administration (FDA), pharmacies and healthcare providers seek ways to improve and streamline its administration. Created in 2007 as part of the FDA Amendments Act, REMS was designed to ensure that the benefits of a drug or biological product outweigh its risks, as well as for post-marketing surveillance of medication safety. While providers agree with these goals, many are also concerned with issues they believe are preventing REMS from achieving its objectives.

Download White Paper

You may also like:

Blog Post

Results released last month from the 2019 J.D. Power  U.S. Pharmacy Satisfaction Study showed that patients enjoy visiting brick-and-mort...

View Blog Post
Blog Post

Many providers and pharmacists are already well into influenza vaccination season, as they and the healthcare organizations for which they work have (rightly!) been encouraging patients to get vaccinated since early September (...

View Blog Post
Blog Post

CBD (cannabidiol) is widely available in stores and on the Internet and is often viewed a perfect solution for all sorts of ailments, since it acts similarly to cannabis, but without the THC that gives the high or stoned feelin...

View Blog Post

Filter by Type

Sign up to receive the latest news and information!

Sign Up